1. Bayer Schering Pharma Clinical Development in Asia Pacific and Japan Dr. Rolf Schürmann Vice-President, Head of Global Clinical Development Women’s Healthcare Bayer…

1. Recent Advances In The Development Of Innovative Therapies. The Celgene Pipeline Jean Caraux, MD PhD BTG, Hong Kong - February 23th 2013 2. 2 Targeting Unmet Medical Needs…

1. May 2012 CORTHOUGHTS …a slow-burningcollection ofstem celldisorders that have clinicians handcuffed when it comes toofferingmeaningfulinterventions. Myelofibrosis and…

Low grade glioma Radiotherapy in low grade gliomas benefit with local control advantage Patients with high risk factors need immediate radiation after surgery RT dose of…

Slide 1 Peri-Operative Chemotherapy Is the Best Approach Wells Messersmith, MD, FACP Professor Director, Gastrointestinal Medical Oncology Program Program co-Leader, Developmental…

C. Schuhmacher, P.M. Schlag, F. Lordick, W. Hohenberger, J. Heise, C. Haag, S. Gretschel, M. Mauer, M.P. Lutz, J.R. Siewert Neoadjuvant chemotherapy versus surgery alone…

Charles D. Blanke, M.D., F.A.C.P. OHSU Cancer Institute Metastatic Colorectal Cancer: What to Use (or not), How to Prevent Toxicity (or not) and Whom to Treat (or not) Abstract…

PowerPoint Presentation Peri-Operative Chemotherapy Is the Best Approach Wells Messersmith, MD, FACP Professor Director, Gastrointestinal Medical Oncology Program Program…

Slide 1 A Phase III study (EMBRACE*) of eribulin mesylate vs. treatment of physician’s choice in patients with locally recurrent or metastatic breast cancer previously…